The reduction in frataxin expression leads to oxidative stress, mitochondrial iron accumulation and consequential cell death with the primary sites of neurons of the dorsal root ganglia and the dentate nucleus of the cerebellum, contributing to symptoms of progressive ataxia, muscle weakness, and sensory deficit [16]–[20]. The gene discussed is FXN; the disease is Ataxia.